Collegium Pharmaceutical, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $4.1M | $134.9M | $153.2M |
| FY2017 | — | $104.1M | $118.7M |
| FY2018 | $11.5M | $91.6M | $146.6M |
| FY2019 | $11.5M | $87.4M | $170.0M |
| FY2020 | — | $186.0M | $174.1M |
| FY2021 | — | $202.9M | $186.4M |
| FY2022 | — | $194.8M | $173.7M |
| FY2023 | — | $195.4M | $238.9M |
| FY2024 | — | $228.8M | $70.6M |
| FY2025 | — | $301.7M | $231.3M |